BETAHISTINE GxP betahistine dihydrochloride 16 mg tablets blister packs

Country: Ástralía

Tungumál: enska

Heimild: Department of Health (Therapeutic Goods Administration)

Virkt innihaldsefni:

betahistine dihydrochloride, Quantity: 16 mg

Fáanlegur frá:

Arrotex Pharmaceuticals Pty Ltd

INN (Alþjóðlegt nafn):

betahistine dihydrochloride

Lyfjaform:

Tablet, uncoated

Samsetning:

Excipient Ingredients: purified talc; mannitol; microcrystalline cellulose; citric acid; colloidal anhydrous silica

Stjórnsýsluleið:

Oral

Einingar í pakka:

10 tablets, 30 tablets, 60 tablets, 100 tablets, 25 tablets

Gerð lyfseðils:

(S4) Prescription Only Medicine

Ábendingar:

Meniere's Syndrome as defined by the following core symptoms: vertigo (with nausea/vomiting), hearing loss (hardness of hearing) and tinnitus.

Vörulýsing:

Visual Identification: Uncoated, round, biconvex, white to light creamy tablets, with a groove on one surface.; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Leyfisstaða:

Licence status A

Leyfisdagur:

2014-08-14